Literature DB >> 20059355

Pediatric HIV clinical care resources and management practices in Asia: a regional survey of the TREAT Asia pediatric network.

Wasana Prasitsuebsai1, Asha C Bowen, Joselyn Pang, Cees Hesp, Azar Kariminia, Annette H Sohn.   

Abstract

Characterizing intraregional differences in current pediatric HIV care and treatment in Asia can guide the development of clinical practice guidelines and improve the understanding of local resource availability. The Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia) Pediatric Program is a collaboration of clinics and referral hospitals studying pediatric HIV outcomes in the region. A Web-based survey to characterize clinical management practices and monitoring resources was developed and distributed to 20 sites in January 2008. Seventeen (85%) sites from 6 countries responded through April 2008; 14 (82%) were hospital-based and 16 (94%) were public facilities. Of 4050 HIV-infected children under care, 3606 (89%) were on antiretroviral treatment; 80% were on their first mono-, dual-, or triple-drug regimen and 74% were on nevirapine- or efavirenz-based regimens. Fifteen (88%) sites had consistent access to polymerase chain reaction (PCR) testing for infant diagnosis. All sites had access to CD4 testing, with 13 (76%) routinely monitoring patients every 3-6 months; 7 (41%) sites monitored viral load at 6- to 12-month intervals. Although there is some variation in clinical practices, high levels of treatment and monitoring resources were available at these sites. The availability of PCR for early infant diagnosis positions them to implement recent WHO recommendations to treat HIV-infected children younger than 1 year of age. This information will be used to develop future research and programs to support children with HIV in Asia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20059355      PMCID: PMC2835391          DOI: 10.1089/apc.2009.0224

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  18 in total

1.  Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.

Authors:  Rohan Hazra; Sonia K Stoszek; Laura Freimanis Hance; Jorge Pinto; Heloisa Marques; Mario Peixoto; Jorge Alarcon; Marisa Mussi-Pinhata; Leslie Serchuck
Journal:  Int J Epidemiol       Date:  2008-11-26       Impact factor: 7.196

2.  Effect of antiretroviral therapy in human immunodeficiency virus-infected children.

Authors:  Pimpanada Chearskul; Kulkanya Chokephaibulkit; Sanay Chearskul; Wanatpreeya Phongsamart; Nottasorn Plipat; Keswadee Lapphra; Nirun Vanprapar
Journal:  J Med Assoc Thai       Date:  2005-11

3.  Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

Authors:  Ibou Thior; Shahin Lockman; Laura M Smeaton; Roger L Shapiro; Carolyn Wester; S Jody Heymann; Peter B Gilbert; Lisa Stevens; Trevor Peter; Soyeon Kim; Erik van Widenfelt; Claire Moffat; Patrick Ndase; Peter Arimi; Poloko Kebaabetswe; Patson Mazonde; Joseph Makhema; Kenneth McIntosh; Vladimir Novitsky; Tun-Hou Lee; Richard Marlink; Stephen Lagakos; Max Essex
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

4.  Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001.

Authors:  Achara Teeraratkul; R J Simonds; Suvanna Asavapiriyanont; Amphan Chalermchokcharoenkit; Nirun Vanprapa; Tawee Chotpitayasunondh; Philip A Mock; Natapakwa Skunodum; Kanchana Neeyapun; Bongkoch Jetsawang; Mary Culnane; Jordan Tappero
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.731

5.  Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India.

Authors:  N Kumarasamy; Kartik K Venkatesh; Bella Devaleenol; S Poongulali; S N Mothi; Suniti Solomon
Journal:  J Trop Pediatr       Date:  2008-10-01       Impact factor: 1.165

6.  Failure of human immunodeficiency virus enzyme immunoassay to rule out infection among polymerase chain reaction-negative Vietnamese infants at 12 months of age.

Authors:  Annette H Sohn; Tran Chi Thanh; Le Quoc Thinh; Truong Huu Khanh; Huynh Khanh Thu; Le Truong Giang; Truong Xuan Lien
Journal:  Pediatr Infect Dis J       Date:  2009-04       Impact factor: 2.129

7.  How can we simplify antiretroviral therapy in children?

Authors:  Annette H Sohn; Jintanat Ananworanich
Journal:  Curr Opin HIV AIDS       Date:  2007-09       Impact factor: 4.283

8.  Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

Authors:  Alessandro Cozzi-Lepri; Andrew N Phillips; Lidia Ruiz; Bonaventura Clotet; Clive Loveday; Jesper Kjaer; Helene Mens; Nathan Clumeck; Ludmila Viksna; Francisco Antunes; Ladislav Machala; Jens D Lundgren
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

9.  Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care.

Authors:  Johan van Griensven; Ludwig De Naeyer; Jeanine Uwera; Anita Asiimwe; Claire Gazille; Tony Reid
Journal:  BMC Pediatr       Date:  2008-10-02       Impact factor: 2.125

10.  Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.

Authors:  Joseph Kagaayi; Ronald H Gray; Heena Brahmbhatt; Godfrey Kigozi; Fred Nalugoda; Fred Wabwire-Mangen; David Serwadda; Nelson Sewankambo; Veronica Ddungu; Darix Ssebagala; Joseph Sekasanvu; Grace Kigozi; Fredrick Makumbi; Noah Kiwanuka; Tom Lutalo; Steven J Reynolds; Maria J Wawer
Journal:  PLoS One       Date:  2008-12-09       Impact factor: 3.240

View more
  9 in total

Review 1.  Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents.

Authors:  Brian S Eley; Tammy Meyers
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

2.  Therapeutic Drug Monitoring of Lopinavir in HIV-Infected Children on Second-Line Antiretroviral Therapy in Asia.

Authors:  Linda Aurpibul; Sirinya Teerananchai; Wasana Prasitsuebsai; Tavitiya Sudjaritruk; Pope Kosalaraksa; Nia Kurniati; Khanh Huu Truong; Viet Chau Do; Lam Van Nguyen; Kulkanya Chokephaibulkit; Thida Singtoroj; Stephen J Kerr
Journal:  Ther Drug Monit       Date:  2016-12       Impact factor: 3.681

Review 3.  Tackling HIV through robust diagnostics in the developing world: current status and future opportunities.

Authors:  Darash Desai; Grace Wu; Muhammad H Zaman
Journal:  Lab Chip       Date:  2010-12-01       Impact factor: 6.799

4.  Survival of HIV-infected children: a cohort study from the Asia-Pacific region.

Authors:  Pagakrong Lumbiganon; Azar Kariminia; Linda Aurpibul; Rawiwan Hansudewechakul; Thanyawee Puthanakit; Nia Kurniati; Nagalingeswaran Kumarasamy; Kulkanya Chokephaibulkit; Nik Khairulddin Nik Yusoff; Saphonn Vonthanak; Fong Siew Moy; Kamarul Azahar Mohd Razali; Revathy Nallusamy; Annette H Sohn
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

5.  Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings.

Authors:  Reshmie Ramautarsing; Jintanat Ananworanich
Journal:  AIDS Res Ther       Date:  2010-06-23       Impact factor: 2.250

6.  Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database.

Authors:  Rawiwan Hansudewechakul; Virat Sirisanthana; Nia Kurniati; Thanyawee Puthanakit; Pagakrong Lumbiganon; Vonthanak Saphonn; Nik Khairulddin Nik Yusoff; Nagalingeswaran Kumarasamy; Siew Moy Fong; Revathy Nallusamy; Preeyaporn Srasuebkul; Matthew Law; Annette H Sohn; Kulkanya Chokephaibulkit
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

7.  High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting.

Authors:  Thanyawee Puthanakit; Gonzague Jourdain; Piyarat Suntarattiwong; Kulkanya Chokephaibulkit; Umaporn Siangphoe; Tulathip Suwanlerk; Wasana Prasitsuebsai; Virat Sirisanthana; Pope Kosalaraksa; Witaya Petdachai; Rawiwan Hansudewechakul; Naris Waranawat; Jintanat Ananworanich
Journal:  AIDS Res Ther       Date:  2012-06-18       Impact factor: 2.250

8.  A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa.

Authors: 
Journal:  J Int AIDS Soc       Date:  2011-02-09       Impact factor: 5.396

9.  Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement.

Authors:  Sten H Vermund; Meridith Blevins; Troy D Moon; Eurico José; Linda Moiane; José A Tique; Mohsin Sidat; Philip J Ciampa; Bryan E Shepherd; Lara M E Vaz
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.